Document is current
Any future updates will be listed below
-
Authors
Encinas, Cristina https://orcid.org/0000-0002-9001-9754
Lozano, Virginia
Hlavacek, Patrick https://orcid.org/0000-0002-4752-3218
Llinares, Julia
Toribio-Castelló, Sofía https://orcid.org/0000-0001-8879-3057
Carcedo, David https://orcid.org/0000-0002-2809-7399
Asís-Montalt, Jordi https://orcid.org/0009-0001-0004-6469
Martínez-López, Joaquín https://orcid.org/0000-0001-7908-0063
-
Funding
Funding for this research was provided by:
Pfizer SLU
- License Information
-
More Information
Article History
Received: 16 January 2025
Accepted: 21 March 2025
First Online: 7 April 2025
Declarations
:
: Cristina Encinas has received honoraria derived from lectures and participation in advisory boards from Amgen, BMS, GSK, Johnson and Johnson, Menarini Stemline, Sanofi and Pfizer. Virginia Lozano, Patrick Hlavacek, Julia Llinares and Sofía Toribio are employees of Pfizer and may hold Pfizer stock. David Carcedo and Jordi Asís-Montalt are employees of Hygeia Consulting. Joaquín Martínez-López has received honoraria derived from research projects from Amgen, Incity, Janssen and Pfizer, and from lectures and participation in advisory boards from Amgen, BMS, Gilead, Incity, Janssen, Novartis, Pfizer and Roche.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
